Literature DB >> 9029405

Rat strain differences in the vulnerability of serotonergic nerve endings to neurotoxic damage by p-chloroamphetamine.

D Zhou1, M Schreinert, J Pilz, G Huether.   

Abstract

Substituted amphetamines are known to selectively destroy serotonin (5-HT) nerve endings in distant projection fields of the dorsal raphe nuclei and the systemic administration of these drugs is widely used in investigations of the role of the central 5-HT system and of the mechanisms involved in their toxicity. Until now Sprague-Dawley rats were almost exclusively used for this purpose and the findings were thought to apply to other strains as well. We compared the long-term effects of the administration of different doses of para-chloroamphetamine (PCA) on three specific markers of the density of 5-HT presynapses, [3H]-paroxetine binding to 5-HT-transporters, tryptophan hydroxylase apoenzyme contents, and 5-HT levels in the frontal cortex of Sprague-Dawley and Wistar rats. PCA-treatment caused a dose dependent decline of all three parameters which was much more pronounced in Sprague-Dawley compared to Wistar rats. An i.p. dose of 4 mg PCA/kg body weight, which caused a severe, about 90% reduction of all three parameters of 5-HT innervation in Sprague-Dawley rats was almost ineffective in Wistar rats. The dose of 8 mg/kg which was required to eliminate about 80% of cortical 5-HT presynapses in Wistar rats was already lethal to Sprague-Dawley rats. The reasons of this different susceptibility of the 5-HT system in the two rat strains are unknown. Their elucidation will contribute to a better understanding of inherited differences in individual vulnerability to the neurotoxic effects of substituted amphetamines. The combined measurements of transporter density, of tryptophan hydroxylase apoenzyme contents, and of 5-HT levels is a powerful tool for the assessment of experimentally induced changes in the density of 5-HT innervation in distant projection fields of the raphe nuclei.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9029405     DOI: 10.1007/BF01271252

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  59 in total

1.  Evidence for a common mechanism of serotonin release induced by substituted amphetamines in vitro.

Authors:  U V Berger; X F Gu; J W van Lange; E C Azmitia
Journal:  Ann N Y Acad Sci       Date:  1992-05-11       Impact factor: 5.691

2.  The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats.

Authors:  K T Finnegan; J J Skratt; I Irwin; J W Langston
Journal:  Neurosci Lett       Date:  1989-11-06       Impact factor: 3.046

3.  L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.

Authors:  C J Schmidt; C K Black; V L Taylor
Journal:  Eur J Pharmacol       Date:  1991-10-02       Impact factor: 4.432

4.  Unlike systemic administration of p-chloroamphetamine, direct intracerebral injection does not produce degeneration of 5-HT axons.

Authors:  U V Berger; M E Molliver; R Grzanna
Journal:  Exp Neurol       Date:  1990-09       Impact factor: 5.330

5.  Methamphetamine-induced neuronal damage: a possible role for free radicals.

Authors:  M J De Vito; G C Wagner
Journal:  Neuropharmacology       Date:  1989-10       Impact factor: 5.250

6.  Footshock-induced analgesia: its opioid nature depends on the strain of rat.

Authors:  G Urca; S Segev; Y Sarne
Journal:  Brain Res       Date:  1985-03-11       Impact factor: 3.252

7.  The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.

Authors:  U V Berger; X F Gu; E C Azmitia
Journal:  Eur J Pharmacol       Date:  1992-05-14       Impact factor: 4.432

8.  Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA).

Authors:  J M Paris; K A Cunningham
Journal:  Brain Res Bull       Date:  1992-01       Impact factor: 4.077

9.  Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine.

Authors:  M A Wilson; G A Ricaurte; M E Molliver
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

10.  The neurotoxic effects of p-chloroamphetamine in rat brain are blocked by prior depletion of serotonin.

Authors:  U V Berger; R Grzanna; M E Molliver
Journal:  Brain Res       Date:  1992-04-24       Impact factor: 3.252

View more
  1 in total

Review 1.  Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners.

Authors:  G Huether; D Zhou; E Rüther
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.